🇺🇸 PF-07976016 Formulation A in United States

PF-07976016 Formulation A (pf-07976016-formulation-a) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PF-07976016 Formulation A in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is PF-07976016 Formulation A approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PF-07976016 Formulation A in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.